FDA Flu Vaccine Immunization Program

SOL #: 75F40126Q00257Solicitation

Overview

Buyer

Health And Human Services
Food And Drug Administration
FDA OFFICE OF ACQ GRANT SVCS
Rockville, MD, 20852, United States

Place of Performance

Silver Spring, MD

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 17, 2026
2
Submission Deadline
Jul 6, 2026, 2:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Food and Drug Administration (FDA) is soliciting proposals for the procurement and delivery of 2,200 seasonal influenza vaccine doses for the 2026-2027 season. These vaccines are intended for FDA Occupational Health Units (OHUs) at the White Oak Campus in Silver Spring, MD, and the Jefferson Laboratories Campus in Jefferson, AR. This is a Firm-Fixed-Price Type Purchase Order and is not set-aside for small business concerns. Proposals are due Monday, July 6, 2026, by 10:00 AM Eastern.

Scope of Work

The contractor shall procure and deliver 2,200 units of FDA-approved seasonal influenza vaccine for the 2026-2027 season. All doses must be provided in single-dose pre-filled syringes and comply with CDC cold chain requirements for shipping, storage, and handling. Packaging must clearly indicate the manufacturer, National Drug Code (NDC) number, lot number, and expiration date. The total order includes 2,000 units for adults under 65 years of age and 200 units for adults 65 years of age and older. Excluded services include on-site storage/refrigeration, inventory/tracking, clinical staffing, administrative services, logistical planning, and recordkeeping.

Contract Details

  • Contract Type: Firm-Fixed-Price Type Purchase Order.
  • Period of Performance: Anticipated July 20, 2026, through September 2, 2026.
  • Delivery Date: On or before September 1, 2026.
  • Set-Aside: Not set-aside for small business concerns.
  • Product Service Code (PSC): 6505 (Drugs And Biologicals).
  • NAICS Code: 325412.

Submission & Evaluation

Proposals must be submitted electronically via email to Amanda Edger (Amanda.Edger@fda.hhs.gov) by Monday, July 6, 2026, at 10:00 AM Eastern. The email subject line must be "75F40126Q00257- FDA Flu Vaccine Immunization Program." Award will be based on a Lowest Price Technically Acceptable (LPTA) source selection process. Technical factors for acceptability include Quantity, Regulatory Approval, and Packaging. The business/price volume must be complete, accurate, and align with the technical volume, utilizing the provided pricing worksheet (Attachment 1). Questions regarding this solicitation are due by Monday, June 22, 2026, 10:00 AM Eastern. Personnel involved must meet specific residency requirements (3 of the past 5 years in the U.S.).

People

Points of Contact

Amanda EdgerPRIMARY

Files

Files

Download
Download

Versions

Version 1Viewing
Solicitation
Posted: Jun 17, 2026
FDA Flu Vaccine Immunization Program | GovScope